Improving data quality in observational research studies: Report of the Cure Glomerulonephropathy (CureGN) network.
Improving data quality in observational research studies: Report of the Cure Glomerulonephropathy (CureGN) network.
复制标题
改善观察性研究的数据质量:治愈肾小球肾病(CureGN)网络报告。
DOI:
10.1016/j.conctc.2021.100749
复制
发表时间:
2021-06
影响因子:
1.5
通讯作者:
Trachtman H
中科院分区:
文献类型:
--
作者:
Gillespie BW;Laurin LP;Zinsser D;Lafayette R;Marasa M;Wenderfer SE;Vento S;Poulton C;Barisoni L;Zee J;Helmuth M;Lugani F;Kamel M;Hill-Callahan P;Hewitt SM;Mariani LH;Smoyer WE;Greenbaum LA;Gipson DS;Robinson BM;Gharavi AG;Guay-Woodford LM;Trachtman H
High data quality is of crucial importance to the integrity of research projects. In the conduct of multi-center observational cohort studies with increasing types and quantities of data, maintaining data quality is challenging, with few published guidelines. The Cure Glomerulonephropathy (CureGN) Network has established numerous quality control procedures to manage the 70 participating sites in the United States, Canada, and Europe. This effort is supported and guided by the activities of several committees, including Data Quality, Recruitment and Retention, and Central Review, that work in tandem with the Data Coordinating Center to monitor the study. We have implemented coordinator training and feedback channels, data queries of questionable or missing data, and developed performance metrics for recruitment, retention, visit completion, data entry, recording of patient-reported outcomes, collection, shipping and accessing of biological samples and pathology materials, and processing, cataloging and accessing genetic data and materials. We describe the development of data queries and site Report Cards, and their use in monitoring and encouraging excellence in site performance. We demonstrate improvements in data quality and completeness over 4 years after implementing these activities. We describe quality initiatives addressing specific challenges in collecting and cataloging whole slide images and other kidney pathology data, and novel methods of data quality assessment. This paper reports the CureGN experience in optimizing data quality and underscores the importance of general and study-specific data quality initiatives to maintain excellence in the research measures of a multi-center observational study.
登录
查看更多内容
DOI:
10.1111/j.1600-6143.2010.03039.x
发表时间:
2010-07
期刊:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
影响因子:
--
作者:
Gillespie BW;Merion RM;Ortiz-Rios E;Tong L;Shaked A;Brown RS;Ojo AO;Hayashi PH;Berg CL;Abecassis MM;Ashworth AS;Friese CE;Hong JC;Trotter JF;Everhart JE;A2ALL Study Group
通讯作者:
A2ALL Study Group
影响因子:
2.6
作者:
Ercole A;Brinck V;George P;Hicks R;Huijben J;Jarrett M;Vassar M;Wilson L;DAQCORD collaborators
通讯作者:
DAQCORD collaborators
影响因子:
3.7
作者:
Duda, Stephany N.;Shepherd, Bryan E.;McGowan, Catherine C.
通讯作者:
McGowan, Catherine C.
影响因子:
5.1
作者:
Stone, EJ;Osganian, SK;Elder, JP
通讯作者:
Elder, JP
影响因子:
4.5
作者:
Giganti, Mark J.;Shepherd, Bryan E.;Duda, Stephany N.
通讯作者:
Duda, Stephany N.